A total synthesis of the title compound 2, a potential precursor of the progestagens desogestrel and 3‐ketodesogestrel, is described. The backbone of the steroid was assembled by condensation of 1,2‐dihydro‐4,7‐dimethoxynaphthalene (12) and [S‐(Z)]‐8,9‐dihydroxy‐7‐ethyl‐6‐nonen‐2‐ynoic acid methyl ester 9‐(tert‐butyldimethyl)silyl ether (11), prepared from [R‐(+ )]‐glyceraldehyde acetonide (4), and subsequent Claisen rearrangement. Heating of the resulting disecosteroid (14) at 170°C gave a 1:1 mixture of 9,11‐secosteroids, 15 and 16, having the 8α, 13β, 14α‐ and 8α, 13α, 14α‐configuration, respectively. The 13β‐epimer 15 was converted into 11‐bromo‐13‐ethyl‐3‐methoxy‐9,11‐secogona‐1,3,5(10)‐triene‐9,17‐dione (21), which reacted with triphenylphosphine under high pressure conditions (12 kbar, 55°C) to give the corresponding phosphonium salt 22. The intramolecular Wittig reaction of 22 proceeded with epimerization at C‐8 to give exclusively (8α)‐13‐ethyl‐3‐methoxygona‐1,3,5,9(11)‐tetraen‐17‐one (23) which, upon treatment with acid, isomerized to the title compound 2.
No takes yet. Share an insight, caveat, or question.
Groen‐Piotrowska et al. (1993) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: